Organization Overview
Alternative names
adenovirus-specific t-cells (1 trial)
alemtuzumab (campath) (2 trials)
allogeneic stem cells (1 trial)
allogeneic transplant donor lymphocytes, depleted of tcr-αβ t cells and b cells; enriched for nk cells and tcrγδ t cells (1 trial)
autologous cd34+ cells (1 trial)
bk cytotoxic t lymphocytes (1 trial)
brentuximab vedotin (adcetris) (4 trials)
carboplatin (paraplatin) (1 trial)
cladribine (leustatin) (1 trial)
cyclophosphamide (cytoxan) (4 trials)
cytarabine (cytosar-u) (4 trials)
cytomegalovirus-specific cytotoxic t cells (1 trial)
dacarbazine (dtic-dome) (1 trial)
daratumumab (darzalex) (1 trial)
defibrotide (defitelio) (4 trials)
doxorubicin (Doxil) (3 trials)
droxidopa (northera) (1 trial)
etoposide (vepesid) (3 trials)
gemtuzumab ozogamicin (mylotarg) (3 trials)
human placental derived stem cells (2 trials)
lmp-specific cytotoxic t-lymphocytes (2 trials)
lymphocyte immune globulin, anti-thymocyte globulin (equine) (Atgam) (1 trial)
mitoxantrone (novantrone) (2 trials)
2-o, 3-o desulfated heparin (1 trial)
allogeneic hematopoietic stem cells (Hemacord) (1 trial)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (1 trial)
Acute Chest Syndrome (Phase 2)
Adenoviridae Infections (Phase 2)
Adrenoleukodystrophy (Phase 1)
Anemia (Phase 2)
Anemia, Aplastic (Phase 2)
Anemia, Diamond-Blackfan (Phase 2)
Anemia, Sickle Cell (Phase 2)
beta-Thalassemia (Phase 2)
Brain Diseases (Phase 2)
Brain Ischemia (Phase 2)
Burkitt Lymphoma (Phase 2)
Cardiovascular Diseases (Phase 3)
Communicable Diseases (Phase 2)
Coronary Disease (Phase 3)
Cytomegalovirus Infections (Phase 2)
Disease (Phase 2)
Epstein-Barr Virus Infections (Phase 2)
Fever (Phase 3)
Fucosidosis (Phase 1)
Gaucher Disease (Phase 1)
Headache (Phase 3)
Heart Diseases (Phase 3)
Hematologic Diseases (Phase 2)
Hepatoblastoma (Phase 1)
Histiocytosis (Phase 2)
Hodgkin Disease (Phase 2)
Hot Flashes (Phase 3)
Huntington Disease (Phase 4)
Hyperinsulinism (Phase 2)
Hypoxia (Phase 2)
Hypoxia-Ischemia, Brain (Phase 2)
Immunologic Deficiency Syndromes (Phase 2)
Infarction (Phase 3)
Infections (Phase 2)
Infertility (Phase 4)
Insulin Resistance (Phase 2)
Ischemia (Phase 3)
Kidney Diseases (Phase 2)
Leukemia (Phase 2)
Leukemia, Lymphoid (Phase 2)
Leukemia, Myeloid (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Leukemia, Myelomonocytic, Juvenile (Phase 1)
Leukodystrophy, Globoid Cell (Phase 1)
Leukodystrophy, Metachromatic (Phase 1)
Lupus Erythematosus, Systemic (Phase 1)
Lymphoma (Phase 2)
Lymphoma, B-Cell (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Lymphoma, Mantle-Cell (Phase 2)
Lymphoma, T-Cell, Peripheral (Phase 1)
Lymphoproliferative Disorders (Phase 1)
Metabolism, Inborn Errors (Phase 2)
Migraine Disorders (Phase 3)
Mucopolysaccharidoses (Phase 1)
Mucopolysaccharidosis I (Phase 1)
Mucopolysaccharidosis VI (Phase 1)
Multiple Myeloma (Phase 2)
Myelodysplastic Syndromes (Phase 2)
Myocardial Infarction (Phase 3)
Myocardial Ischemia (Phase 3)
Neoplasms (Phase 1)
Neoplasms, Plasma Cell (Phase 2)
Neuroblastoma (Phase 1)
Neuronal Ceroid-Lipofuscinoses (Phase 1)
Neutropenia (Phase 3)
Niemann-Pick Diseases (Phase 1)
Niemann-Pick Disease, Type A (Phase 1)
Niemann-Pick Disease, Type C (Phase 1)
Orthostatic Intolerance (Phase 1)
Pancreatic Neoplasms (Phase 2)
Pancytopenia (Phase 2)
Pick Disease of the Brain (Phase 1)
Preleukemia (Phase 2)
Premature Birth (Phase 3)
Purpura (Phase 1)
Purpura, Thrombocytopenic (Phase 1)
Purpura, Thrombocytopenic, Idiopathic (Phase 1)
Rhabdomyosarcoma (Phase 1)
Sarcoma (Phase 2)
Sarcoma, Ewing (Phase 1)
Sarcopenia (Phase 2)
Scleroderma, Diffuse (Phase 1)
Scleroderma, Systemic (Phase 1)
Sclerosis (Phase 1)
Stress Disorders, Post-Traumatic (Phase 2)
Stress Disorders, Traumatic (Phase 2)
Stress Disorders, Traumatic, Acute (Phase 2)
Syncope (Phase 2)
Syncope, Vasovagal (Phase 2)
Syndrome (Phase 2)
Tachycardia (Phase 2)
Thalassemia (Phase 2)
Thrombocytopenia (Phase 2)
Thromboembolism (Phase 2)
Venous Thromboembolism (Phase 2)
Virus Diseases (Phase 2)
Wilms Tumor (Phase 1)
Wolman Disease (Phase 1)
